90747-46-9 Usage
Uses
Used in Pharmaceutical Industry:
4-(1H-Imidazol-2-yl)-piperidine 2HCL is used as an intermediate in the synthesis of pharmaceuticals for its ability to interact with biological systems, contributing to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 4-(1H-Imidazol-2-yl)-piperidine 2HCL is utilized as an intermediate in the synthesis of agrochemicals, playing a crucial role in the development of products that can protect crops and enhance agricultural productivity.
Used in Medicinal Chemistry Research:
4-(1H-Imidazol-2-yl)-piperidine 2HCL is employed as a research compound in medicinal chemistry for studying its potential antifungal and antibacterial properties, which could lead to the discovery of new treatments for various infections and diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 90747-46-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,0,7,4 and 7 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 90747-46:
(7*9)+(6*0)+(5*7)+(4*4)+(3*7)+(2*4)+(1*6)=149
149 % 10 = 9
So 90747-46-9 is a valid CAS Registry Number.
InChI:InChI=1/C8H13N3.2ClH/c1-3-9-4-2-7(1)8-10-5-6-11-8;;/h5-7,9H,1-4H2,(H,10,11);2*1H
90747-46-9Relevant academic research and scientific papers
Discovery of imidazo[1,5-c]imidazol-3-ones: Weakly basic, orally active factor Xa inhibitors
Imaeda, Yasuhiro,Kuroita, Takanobu,Sakamoto, Hiroki,Kawamoto, Tetsuji,Tobisu, Mamoru,Konishi, Noriko,Hiroe, Katsuhiko,Kawamura, Masaki,Tanaka, Toshimasa,Kubo, Keiji
experimental part, p. 3422 - 3436 (2009/04/06)
The coagulation enzyme factor Xa (FXa) has been recognized as a promising target for the development of new antithrombotic agents. We previously found compound 1 to be an orally bioavailable FXa inhibitor in fasted monkeys; however, 1 showed poor bioavail
HETEROARYLPIPERIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY
-
Page 66, (2008/06/13)
The present invention is directed to compounds of the formula (I): (wherein R>12345610 and n are defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptor CCR-2.
